N Latex FLC – new monoclonal high-performance assays for the determination of free light chain kappa and lambda : Clinical Chemistry and Laboratory Medicine Jump to ContentJump to Main Navigation
Show Summary Details

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Schlattmann, Peter / Tate, Jillian R. / Tsongalis, Gregory J.


IMPACT FACTOR increased in 2015: 3.017
Rank 5 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982
Impact per Publication (IPP) 2015: 2.238

249,00 € / $374.00 / £187.00*

Online
ISSN
1437-4331
See all formats and pricing

 


Select Volume and Issue
Loading journal volume and issue information...

N Latex FLC – new monoclonal high-performance assays for the determination of free light chain kappa and lambda

1, 2 / Ingrid Knop1 / Peter Stam1 / Monic van den Broek1 / Hannie Klaasse Bos2 / Suzanne Hol1 / Elisa Teunissen1 / Karin Schulte Fischedick1 / Harald Althaus3 / Brigitta Schmidt3 / Carola Wagner3 / Roel Melsert1

1Sanquin Reagents, Sanquin Blood Supply, Amsterdam, The Netherlands

2Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Academic Medical Center, Amsterdam, The Netherlands

3Department of Plasma Proteins, Siemens Healthcare Diagnostics, Marburg, Germany

Corresponding author: Dr. Henk te Velthuis, Department of R&D, Sanquin Reagents, Plesmanlaan 125, 1066CX Amsterdam, The Netherlands Phone: +31 20 512 3665, Fax: +31 20 512 3170

©2011 by Walter de Gruyter Berlin Boston. This content is open access.

Citation Information: Clinical Chemistry and Laboratory Medicine. Volume 49, Issue 8, Pages 1323–1332, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: 10.1515/CCLM.2011.624, June 2011

Publication History

Received:
2011-03-03
Accepted:
2011-03-22
Published Online:
2011-06-11

Abstract

Background: High serum concentrations of monoclonal free light chain (FLC) kappa or lambda are markers of plasma cell dyscrasia.

Methods: We developed new, latex-enhanced, specific nephelometric assays based on monoclonal antibodies for the determination of FLC kappa and lambda in serum, EDTA plasma and Li-heparin plasma for use on the Siemens BN™ systems.

Results: Reference ranges were determined from 369 samples: FLC kappa 6.7–22.4 mg/L, FLC lambda 8.3–27.0 mg/L and kappa/lambda ratio 0.31–1.56. Protection from falsely low results due to antigen excess is obtained with a built-in pre-reaction in the assay protocols. Lot-to-lot consistency between three different lots of reagent, calibrators and supplementary reagent lots showed normalized differences <7.5%. The reproducibility of serum samples varied between 4% and 7%. The method comparison with Freelite™ assays showed normalized differences of 19.7%, 32.7% and 21.7%, respectively, for FLC kappa, lambda and ratio, correlations of 0.94, 0.77 and 0.73, and concordance rates of 99.2%, 94.2% and 95%.

Conclusions: N Latex FLC demonstrates high precision, good lot-to-lot consistency and freedom from a high-dose hook effect. The method comparison between Freelite™ and the N Latex FLC assays showed good clinical concordance. Further studies need to reveal the clinical value of the new FLC assays.

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Hugh D. Carr-Smith, Ellen L. Jenner, Josie A.R. Evans, and Stephen J. Harding
Clinical Chemistry and Laboratory Medicine (CCLM), 2016, Volume 0, Number 0
[2]
Joannes F.M. Jacobs, Jillian R. Tate, and Giampaolo Merlini
Clinical Chemistry and Laboratory Medicine (CCLM), 2015, Volume 0, Number 0
[3]
Martijn M. VanDuijn, Joannes F. M. Jacobs, Ron A. Wevers, Udo F. Engelke, Irma Joosten, and Theo M. Luider
Analytical Chemistry, 2015, Page 150728144452005
[4]
Antony R. Parker, Oscar Berlanga, and Stephen Harding
BioMed Research International, 2015, Volume 2015, Page 1
[5]
Frank Bridoux, Nelson Leung, Colin A Hutchison, Guy Touchard, Sanjeev Sethi, Jean-Paul Fermand, Maria M Picken, Guillermo A Herrera, Efstathios Kastritis, Giampaolo Merlini, Murielle Roussel, Fernando C Fervenza, Angela Dispenzieri, Robert A Kyle, and Samih H Nasr
Kidney International, 2015, Volume 87, Number 4, Page 698
[6]
Punit Yadav, Nelson Leung, Paul W Sanders, and Paul Cockwell
Kidney International, 2015, Volume 87, Number 4, Page 692
[7]
Petter Urdal, Erik K. Amundsen, Karin Toska, and Olav Klingenberg
Scandinavian Journal of Clinical & Laboratory Investigation, 2014, Volume 74, Number 7, Page 575
[8]
Han-Sung Kim, Hyun Soo Kim, Kyu-Sung Shin, Wonkeun Song, Hyo Jung Kim, Hyeong Su Kim, and Min-Jeong Park
BioMed Research International, 2014, Volume 2014, Page 1
[9]
Ellen Jenner
Clinica Chimica Acta, 2014, Volume 427, Page 15
[10]
Lola Máiz Suárez, Nuria Garnacho Gayarre, Julia Cabo del Riego, Manuel Penedo Pita, Dolores Formoso Lavandeira, and Ramiro Rueda Rúa
Revista del Laboratorio Clínico, 2013, Volume 6, Number 1, Page 18
[11]
Joannes F.M. Jacobs, Rein M.J. Hoedemakers, Elisa Teunissen, Renate G. van der Molen, and Henk te Velthuis
Clinica Chimica Acta, 2012, Volume 413, Number 19-20, Page 1708
[12]
Rein M.J. Hoedemakers, Johannes F.M. Pruijt, Suzanne Hol, Elisa Teunissen, Henk Martens, Peter Stam, Roel Melsert, and Henk te Velthuis
Clinical Chemistry and Laboratory Medicine, 2012, Volume 50, Number 3

Comments (0)

Please log in or register to comment.